Elis: Disclosure of trading in own shares occured from August 4 to August 8, 2025

Could the disclosed trades affect the company's share float and liquidity in the short term? What potential regulatory penalties or investigations could arise from this activity? How does this self‑trading behavior compare to recent disclosures by peers in the same industry? Will this disclosure impact the confidence of institutional investors or lead to changes in ownership structure? Are there any upcoming corporate actions (e.g., secondary offerings, buybacks) that could be influenced by this trading activity? What steps is the company taking to mitigate any negative impact on its reputation and stock price? What was the volume and price of the shares traded by the company during this period? Who within the company executed the trades and what positions do they hold? Is this disclosure indicative of potential insider trading or non‑compliance with regulations? How might the market react to the negative sentiment associated with this self‑trading disclosure?